u/yannick_barros

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

glucagon-receptor contribution is incretin for dual and triple agonism

amylin is not GLP-1, posts conflating them get corrected

Asked 9 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

CGM traces tell a story, numbers alone do not

A1c, CGM, stacking with metformin

What was the dosing schedule in that arm?

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

Respectfully this is a sample of one presented as a finding.

triple agonism is phase 2, do not generalise

amylin is not GLP-1, posts conflating them get corrected

Same experience. Week 58 and it simply stopped. I know that is not useful information but it is what happened.

API transparency is the question that separates good compounders from sketchy ones

Yes, exactly this, and it is the bit that took me 17 weeks to accept.

Did you actually measure heart rate or is that a feeling?

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

the food-noise thing stops around week 37 for most people

Sceptical. If this were true we would see it reflected in the data and we do not.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.